Urease activity in Cryptococcus neoformans and Cryptococcus gattii;Diferencias en la actividad de la enzima ureasa entre Cryptococcus neoformans y Cryptococcus gattii

Revista Iberoamericana de Micologia

Volumn 25, Issue 1, 2008, Pages 27-31

  Torres Rodríguez, Josep M ^a   Alvarado Ramírez, Eidi ^a   Gutiérrez Gallego, Ricardo ^b  

^a INST MUNIC D INVESTIGACIO MEDICA   (Spain)

^b UNIVERSITAT POMPEU FABRA   (Spain)

Author keywords

Cryptococcus gattii; Cryptococcus neoformans; Pathogenic factors; Urease

Indexed keywords

UREASE;

ARTICLE; CONTROLLED STUDY; CRYPTOCOCCUS; CRYPTOCOCCUS GATTII; CRYPTOCOCCUS NEOFORMANS; ENZYME ACTIVITY; ENZYME SYNTHESIS; FUNGAL STRAIN; FUNGAL VIRULENCE; FUNGUS ISOLATION; INCUBATION TIME; NONHUMAN; PATHOGENICITY; QUANTITATIVE ANALYSIS;

CANAVALIA ENSIFORMIS; CRYPTOCOCCUS GATTII; FILOBASIDIELLA NEOFORMANS;

EID: 42049088050     PISSN: 11301406     EISSN: None     Source Type: Journal    
DOI: 10.1016/s1130-1406(08)70007-x     Document Type: Article

References (28)

1. Atlas RM, Parks LC. Handbook of Microbiological Media. Boca Raton, CRC Press, 1993.
2. Baró T, Torres-Rodríguez JM, De Mendoza MH, Morera Y, Alia C. First identification of autochthonous Cryptococcus neoformans var. gattii isolated from goats with predominantly severe pulmonary disease in Spain. J Clin Microbiol 1998; 36: 458-461.
3. Baró T, Torres-Rodríguez JM, Morera Y, Alia C, Lopez O, Mendez R. Serotyping of Cryptococcus neoformans isolates from clinical and environmental sources in Spain. J Clin Microbiol 1999; 37: 1170-1172.
4. Bava AJ, Negroni R, Bianchi M. Cryptococcosis produced by urease negative strain of Cryptococcus neoformans. J Med Vet Mycol 1993; 31: 87-89.
5. Blackstock R, Buchanan KL, Cherniak R, Mitchell TG, Wong B, Bartiss A, Jackson L, Murphy JW. Pathogenesis of Cryptococcus neoformans is associated with quantitative differences in multiple virulence factors. Mycopathologia 1999; 147: 1-11.
6. Booth JL, Vishniac HS. Urease testing and yeast taxonomy. Can J Microbiol 1987; 33: 396-404.
7. Canteros CE, Rodera L, Rivas MC, Davel G. A rapid urease test for presumptive identification of Cryptococcus neoformans. Mycopathologia 1996; 136: 21-23.
8. Casadevall A, Perfect JR. Cryptococcus neoformans. Washington DC, ASM Press 1998.
9. Chen LC, Blank ES, Casadevall A. Extracellular proteinase activity of Cryptococcus neoformans. Clin Diagn Lab Immunol 1996; 5: 570-574.
10. Colom MF, Frases S, Ferrer C, Jover A, Andreu M, Reus S, Sánchez M, Torres-Rodríguez JM. First local case of human cryptococcosis due to Cryptococcus neoformans var. gattii in Spain. J Clin Microbiol 2005; 43: 3548-3550.
11. Cox GM, Mukherjee J, Cole GT, Casadevall A, Perfect JR. Urease as a virulence factor in experimental cryptococcosis. Infect Immun 2000; 68: 443-448.
12. Doering TL, Nosanchuk JD, Roberts WK, Casadevall A. Melanin as a potential cryptococcal defence against microbicidal proteins. Med Mycol 1999; 37: 175-181.
13. Dromer F, Mathoulin S, Dupont B, Laporte A. Epidemiology of cryptococcosis in France: a 9-year survey (1985-1993). French Cryptococcosis Study Group. Clin Infect Dis 1996; 23: 82-90.
14. Kidd SE, Hagen F, Tscharke RL, Huynh M, Bartlett KH, Fyfe M, Macdougall L,Boekhout T, Kwon-Chung KJ, Meyer W. A rare genotype of Cryptococcus gattii caused the cryptococcosis outbreak on Vancouver Island (British Columbia, Canada). Proc Natl Acad Sci USA 2004; 101: 17258-17263.
15. Kwon-Chung KJ, Bennett JE. Epidemiologic differences between the two varieties of Cryptococcus neoformans. Am J Epidemiol 1984; 120: 123-130.
16. Kwon-Chung KJ, Wickes BL, Booth JL, Vishniac HS, Bennett JE. Urease inhibition by EDTA in the two varieties of Cryptococcus neoformans. Infect Immun 1987; 55: 1751-1754.
17. Kwon-Chung KJ, Boekhout T, Fell JW, Diaz M. Proposal to conserve the name Cryptococcus gattii against C. hondurianus and C. bacillisporus (Basidiomycota, Hymenomycetes, Tremellomycetidae). Taxon 2002; 51: 804-806.
18. Mathur S, Suller MT, Stickler DJ, Feneley RC. Factors affecting crystal precipitation from urine in individuals with long-term urinary catheters colonized with urease-positive bacterial species. Urol Res 2006; 34: 173-177.
19. Mc Gee DJ, Coker C, Testerman TL, Harro JM, Gibson SV, Moblery HL. The Helicobacter pylori f1bA flagellar biosynthesis and regulatory gene is required for motility and virulence and modulates urease of H. pylori and Proteus mirabilis. J Med Microbiol 2002; 51: 958-970.
20. Morera-López Y, Torres-Rodríguez JM, Jiménez-Cabello T, Baró-Tomás T, Alía-Aponte C, Lázera MS. DNA fingerprinting pattern and susceptibility to antifungal drugs in Cryptococcus neoformans variety grubii isolates from Barcelona city and rural environmental samples. Mycopathologia 2005; 160: 9-14.
21. Olszewski MA, Noverr MC, Chen GH, Toews GB, Cox GM, Perfect JR, Huffnagle GB. Urease expression by Cryptococcus neoformans promotes microvascular sequestration, thereby enhancing central nervous system invasion. Am J Pathol 2004; 164: 1761-1771.
22. Seeliger HP. Use of a urease test for the screening and identification of cryptococci. J Bacteriol 1956; 72: 127-131.
23. Sorrell T. Cryptococcus neoformans variety gattii. Med Mycol 2001; 39: 155-168.
24. Speed B, Dunt D. Clinical and host differences between infections with the two varieties of Cryptococcus neoformans. Clin Infect Disc 1995; 21: 28-36.
25. Torres-Rodríguez JM, Morera Y, Baró T, Corominas JM, Castañeda E. Pathogenicity of Cryptococcus neoformans var. gattii in an immunocompetent mouse model. Med Mycol 2002; 41: 59-63.
26. Torres-Rodríguez JM, Hermoso de Mendoza M, Alvarado-Ramírez E, Segura-Roca G. Cryptococcosis by Cryptococcus gattii in immunocompetent goats in Spain and review of the literature. Acta Sci Vet 2006; 34: 245-253.
27. Vidotto V, Leone R, Sinicco A, Ito-kuwa S, Criseo G. Comparison of phospholipase production in Cryptococcus neoformans isolates from AIDS patients and bird droppings. Mycopathologia 1998; 142: 71-76.
28. Warren NG, Hazen KC. Candida, Cryptococcus, and other yeasts of medical importance. En: Murray PR, Baron EJ, Pfaller MA, Tenover FC, Yolken RH (Eds.) Manual of Clinical Microbiology. Sexta edición. Washington, ASM, 1995: 723-737.